Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence

International Journal of Colorectal Disease

Volumn 25, Issue 5, 2010, Pages 567-571

  Chen, Chin Hsin ^a,b   Hsieh, Mon Chau ^a,b   Lai, Cheng Chou ^a,b   Yeh, Chien Yuh ^a,b   Chen, Jinn Shiun ^a,b   Hsieh, Pao Shiu ^a,b   Chiang, Jy Ming ^a,b   Tsai, Wen Sy ^a,b   Tang, Reiping ^a,b   Changchien, Chung Rong ^a,b   Wang, Jeng Yi ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

CEA; Colorectal cancer; Leadtime; Overall survival rates; Recurrence

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; REOPERATION; SURVIVAL RATE;

CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RECURRENCE; SURVIVAL RATE; TIME FACTORS;

EID: 77953289729     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-0889-6     Document Type: Article

References (25)

1. Gold P, Freedman SO (1965) Demonstration of tumor-specific antigen in human colonic carcinoma by immunological tolerance and absorption techniques. J Exp Med 121:439-462
2. Fletcher RH (1986) Carcinoembryonic antigen. Ann Intern Med 104:66
3. Cutait R, Alves VAF et al (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34(10):917-920
4. Moertel CG, Fleming A, Thomas R et al (1993) An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 270(8):943-947
5. Beart RW, O'Connell MJ (1983) Postoperative follow-up of patients with carcinoma of the colon. Mayo Clin Proc 58:361-363
6. Törnqvist A, Ekelund G, Leandoer L (1982) The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg 69(12):725-728
7. Barillari P, Ramacciato G et al (1996) Surveillance of colorectal cancer. Diseases of the Colon & Rectum 39(4):388-393
8. Wenzl E, Wunderlich M, Herbst F, Schemper M, Feil W, Rauhs R, Schiessel R (1988) Results of a rigorous follow-up system in colorectal cancer. Int J Colorectal Dis 3(3):176-180
9. Kievit J, van de velde CJ (1990) Utility and cost of carcinoembryonic antigen monintoring in colon cancer follow-up evaluation: a Markov analysis. Cancer 65:2580
10. National Comprehensive Cancer Network. Available online at www.nccn.org
11. American Society of Clinical Oncology. Published on J Clin Oncol 2005; 23:8512
12. Goldberg RM, Fleming TR, Tangen CM et al (1998) Surgery for recurrent colon cancer: strategies for identifying respectable recurrence and success rate after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27
13. Quentmeier A, Schlag P, Smok M, herfarth C (1990) Re-operation for recurrent colon cancer: the importance of early diagnosis for respectability and survival. Eur J Surg Oncol 16:219
14. Bruinvels DJ, Stiggelbout Am, Kievit J et al (1998) Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg 228:59
15. Ovaska H, Harvinen H, Kujari H et al (1994) Follow-up of patients operated on for colorectal carcinoma. Am J Surg 219:174
16. Wang JY, Wu CH, Lu CY et al (2006) Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis. World J Surg 30(6):1007-13
17. Sadahiro S, Suzuki T et al (2007) Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol 14(3):1092-1098
18. Rosenberg R, Hoos A, Mueller J, Nekarda H (2000) Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer. Br J Cancer 83(10):1323-9
19. Rosenberg R, Hoos A et al (2002) Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 20(4):1049-1055
20. Wang Y, Jatkoe T, Zhang Y et al (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J Clin Oncol 22:1564-1571
21. Koch M, Kienele P, Kastrati D et al (2006) Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer 118:3072-3077
22. Uen YH, Lin SR, Wu DC et al (2007) Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg 246:1041-1046
23. Staab HJ, Anderer FA, Stumpf E et al (1985) Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg 149:198-204
24. Korner H, Soreide K, Stokkeland PJ, Soreide JA (2007) Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol 14:417-23
25. Tang RP, Yeh CY, Wang JY et al (2009) Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. Ann Surg Oncol 16:2516-2523